“[Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management]” (2016) Farmeconomia. Health economics and therapeutic pathways, 17(2S), pp. 13–36. doi:10.7175/fe.v17i2S.1230.